Microdosing with classical psychedelics: Research trajectories and practical considerations
Transcultural Psychiatry October 1, 2022 Alice Wong, Amir Raz 10 citations
Microdosing—taking tiny, non-hallucinogenic amounts of psychedelics like LSD and psilocybin repeatedly—has become common but remains understudied. Users report improved creativity, productivity, and mood. This critical integrative synthesis examines the psychobiological science of dose amounts to help distinguish genuine drug effects from expectations. It outlines regulatory obstacles for Schedule I drugs in the United States and proposes future research directions in cognitive neuroscience, consciousness studies, and mental health.